Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 63 results.
User Information
Export Records
  1. 1.   Early Intervention in STAT3 Dominant-Negative Disease
  2. An, Zixiao Annie; Williams, Kelli W; Urban,Amanda; Ali, Sania; Roy, Susan; Lafeer, Christine; Heimall, Jennifer; Dimitriades, Victoria R; Davis, Joie; Kong, Heidi H; Cowen, Edward W; Holland, Steven M; Freeman, Alexandra F
  3. The Journal of Allergy and Clinical Immunology. In Practice. 2023, Sep 06;
  1. 2.   Dysregulation of interleukin 5 expression in familial eosinophilia.
  2. Prakash Babu, Senbagavalli; Chen, Yun-Yun K; Bonne-Annee, Sandra; Yang, Jun; Maric, Irina; Myers, Timothy G; Nutman, Thomas B; Klion, Amy D
  3. Allergy. 2017, Sep; 72(9): 1338-1345.
  1. 3.   Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency
  2. Cuellar-Rodriguez, J.; Gea-Banacloche, J.; Freeman, A. F.; Hsu, A. P.; Zerbe, C. S.; Calvo, K. R.; Wilder, J.; Kurlander, R.; Olivier, K. N.; Holland, S. M.; Hickstein, D. D.
  3. Blood. 2011, Sep; 118(13): 3715-3720.
  1. 4.   Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy
  2. Joshi, A.; Garg, H.; Ablan, S.; Freed, E. O.; Nagashima, K.; Manjunath, N.; Shankar, P.
  3. Virology. 2011, Jul; 415(2): 95-106.
  1. 5.   Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)
  2. Heimall, J.; Davis, J.; Shaw, P. A.; Hsu, A. P.; Gu, W. J.; Welch, P.; Holl, S. M.; Freeman, A. F.
  3. Clinical Immunology. 2011, Apr; 139(1): 75-84.
  1. 6.   Possession of HLA Class II DRB1*1303 Associates with Reduced Viral Loads in Chronic HIV-1 Clade C and B Infection
  2. Julg, B.; Moodley, E. S.; Qi, Y.; Ramduth, D.; Reddy, S.; Mncube, Z.; Gao, X. J.; Goulder, P. J.; Detels, R.; Ndung'u, T.; Walker, B. D.; Carrington, M.
  3. Journal of Infectious Diseases. 2011, Mar; 203(6): 803-809.
  1. 7.   Mutation Discovered in a Feline Model of Human Congenital Retinal Blinding Disease
  2. Menotti-Raymond, M.; Deckman, K. H.; David, V.; Myrkalo, J.; O'Brien, S. J.; Narfstrom, K.
  3. Investigative Ophthalmology & Visual Science. 2010, Jun; 51(6): 2852-2859.
  1. 8.   Pathogenesis of Hyper IgE Syndrome
  2. Heimall, J.; Freeman, A.; Holland, S. M.
  3. Clinical Reviews in Allergy & Immunology. 2010, Feb; 38(1): 32-38.
  1. 9.   A second-site suppressor significantly improves the defective phenotype impolsed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein
  2. Tang, S. X.; Ablan, S.; Dueck, M.; Ayala-Lopez, W.; Soto, B.; Caplan, M.; Nagashima, K.; Hewlett, I. K.; Freed, E. O.; Levin, J. G.
  3. Virology. 2007, Mar; 359(1): 105-115.
  1. 10.   The tetraspanin protein peripherin-2 forms a complex with melanoregulin, a putative membrane fusion regulator
  2. Boesze-Battaglia, K.; Song, H. M.; Sokolov, M.; Lillo, C.; Pankoski-Walker, L.; Gretzula, C.; Gallagher, B.; Rachel, R. A.; Jenkins, N. A.; Copeland, N. G.; Morris, F.; Jacob, J.; Yeagle, P.; Williams, D. S.; Damek-Poprawa, M.
  3. Biochemistry. 2007, Feb; 46(5): 1256-1272.
  1. 11.   Binding characteristics of IFN-alpha subvariants to IFNAR2-EC and influence of the 6-histidine tag
  2. Schmeisser, H.; Kontsek, P.; Esposito, D.; Gillette, W.; Schreiber, G.; Zoon, K. C.
  3. Journal of Interferon and Cytokine Research. 2006, Dec; 26(12): 866-876.
  1. 12.   Onset and progression in inherited ALS determined by motor neurons and microglia
  2. Boillee, S.; Yamanaka, K.; Lobsiger, C. S.; Copeland, N. G.; Jenkins, N. A.; Kassiotis, G.; Kollias, G.; Clevel, D. W.
  3. Science. 2006, JUN 2; 312(5778): 1389-1392.
  1. 13.   Diversity and duplication of DQB and DRB-like genes of the MHC in baleen whales (suborder : Mysticeti)
  2. Baker, C. S.; Vant, M. D.; Dalebout, M. L.; Lento, G. M.; O'Brien, S. J.; Yuhki, N.
  3. Immunogenetics. 2006, May; 58(4): 283-296.
  1. 14.   Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag
  2. Rulli, S. J.; Muriaux, D.; Nagashima, K.; Mirro, J.; Oshima, M.; Baumann, J. G.; Rein, A.
  3. Virology. 2006, Apr; 347(2): 364-371.
  1. 15.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 16.   Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
  2. Frahm, N.; Kiepiela, P.; Adams, S.; Linde, C. H.; Hewitt, H. S.; Sango, K.; Feeney, M. E.; Addo, M. M.; Lichterfeld, M.; Lahaie, M. P.; Pae, E.; Wurcel, A. G.; Roach, T.; St John, M. A.; Altfeld, M.; Marincola, F. M.; Moore, C.; Mallal, S.; Carrington, M.; Heckerman, D.; Allen, T. M.; Mullins, J. I.; Korber, B. T.; Goulder, P. J. R.; Walker, B. D.; Br, er
  3. Nature Immunology. 2006, FEB; 7(2): 173-178.
  1. 17.   Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin
  2. Tanaka, Y.; Igarashi, S.; Nakamura, M.; Gafni, J.; Torcassi, C.; Schilling, G.; Crippen, D.; Wood, J. D.; Sawa, A.; Jenkins, N. A.; Copeland, N. G.; Borchelt, D. R.; Ross, C. A.; Ellerby, L. M.
  3. Neurobiology of Disease. 2006, FEB; 21(2): 381-391.
  1. 18.   Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history
  2. Traherne, J. A.; Horton, R.; Roberts, A. N.; Miretti, M.; Hurles, M. E.; Stewart, C. A.; Ashurst, J. L.; Atrazhev, A. M.; Coggill, P.; Palmer, S.; Almeida, J.; Sims, S.; Wilming, L. G.; Rogers, J.; de Jong, P. J.; Carrington, M.; Elliott, J. F.; Sawcer, S.; Todd, J. A.; Trowsdale, J.; Beck, S.
  3. Plos Genetics. 2006, Jan; 2(1): 81-92.
  1. 19.   High level of functional polymorphism indicates a unique role of natural selection at human immune system loci
  2. Hughes, A. L.; Packer, B.; Welch, R.; Chanock, S. J.; Yeager, M.
  3. Immunogenetics. 2005, DEC; 57(11): 821-827.
  1. 20.   Prevention of human papilloma virus (HPV) E7-driven tumorigenesis by dominant negative AP-1 (TAM67) appears to be mediated by Cox-2 repression
  2. Matthews, C. P.; Young, M. R.; Colburn, N. H.
  3. Cancer Epidemiology Biomarkers & Prevention. 2005, NOV; 14(11, Part 2 Suppl. S): 2748S-2749S.
  1. 21.   Bayesian risk assessment in genetic testing for autosomal dominant disorders with age-dependent penetrance, including hereditary cancer syndromes
  2. Ogino, S.; Wilson, R. B.; Gold, B.; Flodman, P.
  3. Journal of Molecular Diagnostics. 2005, NOV; 7(5): 654, Abstract G30-655, Abstract G30.
  1. 22.   Retinoic acid-induced downmodulation of telomerase activity in human cancer cells
  2. Xiao, X. D.; Sidorov, I. A.; Gee, J.; Lempicki, R. A.; Dimitrov, D. S.
  3. Experimental and Molecular Pathology. 2005, OCT; 79(2): 108-117.
  1. 23.   Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder
  2. Makishima, T.; Rodriguez, C. I.; Robertson, N. G.; Morton, C. C.; Stewart, C. L.; Griffith, A. J.
  3. Human Genetics. 2005, OCT; 118(1): 29-34.
  1. 24.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 25.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel